According to the latest news report, IFF has been successful in encapsulating NovaSOL Curcumin and NovaSOL Curcumin/Boswellia from AQUANOVA. This news was published in the B2B platform, Nutraceutical Business Review.
For the German-based B2B manufacturer, AQUANOVA, this is the first successful encapsulation of any of their products in a vegan softgel format. With the announcement of the encapsulation success, manufacturers will be able to develop high-quality, strong, plant-based soft-shell capsules that will be at par with the traditional animal-based gelatin that is used for complex ingredients.
SeaGel technology has played an important role in supporting the delivery of high-viscosity ingredients like liquid curcumin. This technology has been used worldwide in non-gelatin soft capsules. Its elasticity, performance, and film strength help in delivering excellent seal strength and superior encapsulation efficiency.
There is a growing demand among consumers for plant-based alternatives in place of animal-based products. Using NovaSOL technology to encapsulate in a vegan softgel format has enhanced the efficacy and addressed the complex development and formulation challenges faced by plant-based ingredients.
Source: IFF’s encapsulation success. Nutraceutical Business Review. 27 March, 2023.
https://nutraceuticalbusinessreview.com/news/article_page/IFFs_encapsulation_success/207805
